Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol Use

NCT02744040 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.

NCT NCT02744040
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02744040 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol Use
Lead sponsor
Fred Hutchinson Cancer Center
Phase
Not applicable
Overall status
Completed
Start date
August 28, 2017
Completion date
November 30, 2020
Enrollment
151 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infection